(Q46959757)

26 December 2017

title

Differential expression patterns of CXCR3 variants and corresponding CXC chemokines in clear cell ovarian cancers and endometriosis (English)

1 reference

26 December 2017

1 reference

1 reference

1

Mitsuko Furuya

1 reference

26 December 2017

author name string

Tomona Yoneyama

2

1 reference

26 December 2017

Etsuko Miyagi

3

1 reference

26 December 2017

Reiko Tanaka

4

1 reference

26 December 2017

Kiyotaka Nagahama

5

1 reference

26 December 2017

Yohei Miyagi

6

1 reference

26 December 2017

Yoji Nagashima

7

1 reference

26 December 2017

Fumiki Hirahara

8

1 reference

26 December 2017

Yoshiaki Inayama

9

1 reference

26 December 2017

Ichiro Aoki

10

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 September 2011

1 reference

26 December 2017

published in

Gynecologic Oncology

1 reference

26 December 2017

volume

122

1 reference

26 December 2017

issue

3

1 reference

26 December 2017

page(s)

648-655

1 reference

26 December 2017

Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.034

Prevalence of ovarian endometriosis in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.034

Ovarian endometrioma--risks factors of ovarian cancer development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.034

Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.034

Pathogenesis of ovarian clear cell adenofibroma, atypical proliferative (borderline) tumor, and carcinoma: clinicopathologic features of tumors with endometriosis or adenofibromatous components support two related pathways of tumor development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.034

Analysis of the clonality of ectopic glands in peritoneal endometriosis using laser microdissection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.034

Endometriosis and the neoplastic process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.034

Detection of chromosomal aneuploidy in endometriosis by multi-color fluorescence in situ hybridization (FISH)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.034

Epithelial Abnormalities in Cystic Ovarian Endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.034

High concentrations of the vascular endothelial growth factor and interleukin-8 in ovarian endometriomata

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.034

Interleukin 1beta, interleukin-6, and tumor necrosis factor-alpha in endometriotic tissue and in endometrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.034

Tumour escape from immune surveillance through dendritic cell inactivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.034

Analysis of the role of chemokines in angiogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.034

7 January 2021

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.034

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.034

Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.034

Requirement of the IFN-alpha/beta-induced CXCR3 chemokine signalling for CD8+ T cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.034

Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.034

CXCR3 internalization following T cell-endothelial cell contact: preferential role of IFN-inducible T cell alpha chemoattractant (CXCL11).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.034

The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.034

The Chemokines CXCL9, CXCL10, and CXCL11 Differentially Stimulate G i-Independent Signaling and Actin Responses in Human Intestinal Myofibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.034

Cellular characteristics of neuroblastoma cells: regulation by the ELR--CXC chemokine CXCL10 and expression of a CXCR3-like receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.034

Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.034

Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.034

CXCL10 promotes invasion-related properties in human colorectal carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.034

Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.034

Up-regulation of CXC chemokines and their receptors: implications for proinflammatory microenvironments of ovarian carcinomas and endometriosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.034

An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.034

Calcineurin inhibitors modulate CXCR3 splice variant expression and mediate renal cancer progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.034

CXCR3-B expression correlates with tumor necrosis extension in renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.034

Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.034

Identification and partial characterization of a variant of human CXCR3 generated by posttranscriptional exon skipping

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.034

10.1016/J.YGYNO.2011.05.034

7 January 2021

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017